跳至主要内容
临床试验/NCT00380263
NCT00380263已完成不适用

Basic Scientific Research Investigating PACAP38 Headache Inducing Effects in Migraine Patients

Danish Headache Center2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2006年11月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2

研究概览

简要总结

To investigate headache score and accompanying symptoms during and after infusion of PACAP38 i migraine patients

详细描述

To investigate headache score and accompanying symptoms during and after infusion of PACAP38

Changes in regional cerebral blood flow (rCBF) in the area supplied by middle cerebral artery (MCA), blood flow in MCA, diameter of the superficial temporal artery (STA) and radial artery (RA)

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy migraine patient without aura
  • Aged 18-50
  • 50-100 kg
  • Fertile women must use safe contraceptives (IUD, oral contraceptives, surgical sterilisation and long lasting gestagen.

排除标准

  • Tension type headache more than five times/month
  • Other primary headaches
  • Daily medication except contraceptives
  • Drug taken within 4 times the halflife for the specific drug except contraceptives
  • Pregnant or lactating women
  • Exposure to radiation within the last year
  • Headache within the last 48 hours before start of trial
  • Hypertension
  • Hypotension
  • Respiratory or cardiac disease

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验